arrow
M

Milan Maçek

Charles University and Motol and Homolka University Hospital
H指数:62
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical benefit without sweat chloride response after ETI therapy in an adult with cystic fibrosis bearing the L467F;F508del complex CFTR allele: a case report and the role of AI-assisted chest CT in longitudinal monitoring

囊性纤维化患者携带L467F;F508del复合CFTR等位基因,接受ETI疗法后无汗氯反应的临床获益:病例报告及AI辅助胸部CT在纵向监测中的作用

2026-08-310
OA
Cascade counselling and testing. Recommendations of the European Society of Human Genetics

级联咨询与检测。欧洲人类遗传学会建议

2025-12-140
OAAI
Global prevalence of CFTR variants with respect to their responsiveness to elexacaftor-tezacaftor-ivacaftor

CFTR变异体对伊莱克萨福特-替扎卡福特-伊卡福特的全球流行率

2025-10-170
OAAI
Comparison of the Effect of CFTR Modulators elexacaftor/tezacaftor/ivacaftor and lumacaftor/ivacaftor via Serum Human Epididymis Protein 4 Concentration in p.Phe508del-CFTR Homozygous Cystic Fibrosis Patients

通过血清人附睾蛋白4浓度比较elexacaftor/tezacaftor/ivacaftor和lumacaftor/ivacaftor对p.Phe508del-CFTR纯合子囊性纤维化患者的影响

2025-09-040
OA
Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease ( vol 18 , e0288907 , 2023)

外显子测序揭示非综合征性胆汁淤积性肝病患者的IFT172变异(vol 18, e0288907, 2023)

2025-01-300
OA
Standards for the care of people with cystic fibrosis (CF); Planning for a longer life

囊性纤维化 (CF) 患者的护理标准; 规划更长的寿命

2024-05-013
PRE
The most common founder pathogenic variant c.868G > A (p.Val290Met) in the NPHS2 gene in a representative adult Czech cohort with focal segmental glomerulosclerosis is associated with a milder disease and its underdiagnosis in childhood
2023-12-191
OAAI
Amelogenesis imperfecta: Next-generation sequencing sheds light on Witkop's classification
2023-05-0922
OAAI